Siemens Healthcare announces FDA clearance for the UROSKOP® Omnia, its new multifunctional workstation for urology. The workstation’s new dynamic flat detector technology UROSKOP Omnia allows the urologist to cover the entire urinary tract – kidney, ureter, bladder (KUB) – with only one single exposure and in superb image quality. With its curved X-ray column, UROSKOP Omnia offers truly unrestricted patient access from all table sides.

Read the full story here

USHIFU has announced the establishment of India HIFU and the launch of Sonablate(R) HIFU services in Hyderabad, India at Dr. Ramayya’s Pramila Hospital for the treatment of prostate disease. The introduction of the Sonablate(R)500 and the HIFU technology for the treatment of prostate cancer marks a major milestone in the practice of urology in the Indian sub-continent. As the population is aging with a healthy lifestyle it is imperative that patients with prostate cancer are offered a viable alternative to the existing therapy options of surgery and radiotherapy.

A  recent research led by Dr Eric A Singer, chief urology resident at the Department of Urology, University of Rochester Medical Center has found that men who regularly took common painkillers like aspirin and ibuprofen and other non-steroidal anti-inflammatory drugs (NSAIDs) had lower circulating levels of PSA (prostate-specific antigen). These levels are the indicators used by doctors to assess whether a person is at risk of prostate cancer. The findings suggest that regular use of NSAIDs lowered PSA levels by almost 10 per cent compared.